These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9381299)

  • 1. [IL-2 post-autologous transplant of hematopoietic stem cells].
    Rayon C
    Sangre (Barc); 1997 Apr; 42 Suppl 1():37. PubMed ID: 9381299
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute myelogenous leukaemia.
    Löwenberg B
    J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
    Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
    Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
    [No Abstract]   [Full Text] [Related]  

  • 5. Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia.
    Arcese W; Meloni G; Giona F; Vegna ML; Testi AM; Annino L; Iori AP; Carotenuto M; Resegotti L; Madon E
    Bone Marrow Transplant; 1991; 7 Suppl 2():38. PubMed ID: 1878711
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment for adult acute myeloid leukemia: where we stand in 1995.
    Wiernik PH
    Acta Haematol Pol; 1995; 26(3):231-7. PubMed ID: 8525767
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)].
    Zittoun R; Rio B; Delmer A; Vekhof A; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):15-6. PubMed ID: 8511034
    [No Abstract]   [Full Text] [Related]  

  • 8. [Successful treatment with idarubicin in a pediatric case of t(8;21) acute myelogenous leukemia with additional chromosomal abnormalities at relapse].
    Wakazono Y; Kataoka A; Fusaoka T; Tunamoto K
    Rinsho Ketsueki; 1998 Jul; 39(7):499-505. PubMed ID: 9750457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of peripheral blood stem cells as rescue after myeloablative therapy.
    Reiffers J; Marit G; Boiron JM; Rice A; Bernard P; Vezon G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():212-4. PubMed ID: 2565746
    [No Abstract]   [Full Text] [Related]  

  • 10. FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience.
    Pastore D; Specchia G; Carluccio P; Liso A; Mestice A; Rizzi R; Greco G; Buquicchio C; Liso V
    Ann Hematol; 2003 Apr; 82(4):231-5. PubMed ID: 12707726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM-IVA, a short induction course for de novo acute myeloid leukemia, suitable for the elderly.
    Pierri I; Clavio M; Miglino M; Cavaliere M; Pietrasanta D; Gobbi M
    Haematologica; 1999 Jun; 84(6):562-3. PubMed ID: 10366806
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia.
    Bassan R; Lerede T; Buelli M; Borleri G; Bellavita P; Rambaldi A; Barbui T
    Haematologica; 1998 May; 83(5):422-7. PubMed ID: 9658726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous stem cell transplantation for advanced acute myeloid leukemia.
    Linker CA; Damon LE; Ries CA; Navarro WA; Case D; Wolf JL
    Bone Marrow Transplant; 2002 Feb; 29(4):297-301. PubMed ID: 11896426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol.
    Oriol A; Ribera JM; Esteve J; Guàrdia R; Brunet S; Bueno J; Pedro C; Llorente A; Tormo M; Besalduch J; Sánchez JM; Batlle M; Vivancos P; Carreras E; Vilà JM; Julià A; Sierra J; Montserrat E; Feliu E;
    Haematologica; 2004 Jul; 89(7):791-800. PubMed ID: 15257930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autotransplantation in acute nonlymphoid leukemia].
    Meloni G; Mandelli F
    Haematologica; 1991 Jun; 76 Suppl 3():321-6. PubMed ID: 1752528
    [No Abstract]   [Full Text] [Related]  

  • 17. Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients.
    Clavio M; Gatto S; Beltrami G; Quintino S; Canepa L; Pierri I; Galbusera V; Carrara P; Miglino M; Varaldo R; Ballerini F; Venturino C; Cerri R; Risso M; Balleari E; Carella AM; Sessarego M; Ghio R; Bacigalupo A; Gobbi M
    J Exp Clin Cancer Res; 2002 Dec; 21(4):481-7. PubMed ID: 12636093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor in post-remission therapy of acute myeloid leukemia.
    Sousa AB; Fernandes JP; Costa I; Ferreira G; Nunes O; Ribeiro P; Neves A; Cruz E; Aveiro F; Rodrigues AS; Bernardo M; Conduto A; Gonçalves AJ; Monteiro A; Sousa M; Soares VH; Veiga J; Gouveia J
    Hematol Cell Ther; 1998 Apr; 40(2):63-6. PubMed ID: 9615248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results in non randomized patients with acute myelogenous leukemia: a single institution experience.
    Deliliers GL; Annaloro C; Oriani A; Della Volpe A; Boschetti C; Cortelezzi A; Maiolo AT
    Ann Ital Med Int; 1998; 13(3):146-51. PubMed ID: 9859570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
    Fukushima T; Ueda T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.